**Background:** Ceramides (CERs) are central to sphingolipid metabolism and are implicated in metabolic dysfunction and cardiovascular risk. Mitochondrial CERs are associated with decreased respiration and increased apoptosis. While CER concentrations are well-studied, methods to measure CER kinetics in vivo are limited. This study aimed to develop a stable isotope method using oral 13C3,15N L-serine to quantify CER 16:0 production in whole liver and isolated hepatic mitochondria in mice fed a control diet (CD) or high-fat diet (HFD) for 2 weeks.
**Methods:** 10-week-old male (n=24) and female (n=24) C57Bl/6 mice were fed CD (10% fat) or HFD (60% fat) for 2 weeks. Mice received an oral bolus of 13C3,15N L-serine (20 mg/kg BW) by intraperitoneal injection on day 0, then in drinking water (0.90 mg/ml) until euthanasia. Four mice per group (2 males, 2 females) were euthanized on days 0, 1, 2, 4, 7, and 12. CERs and dihydroceramides (dhCERs) were extracted from whole liver and isolated hepatic mitochondria and analyzed by HPLC-tandem MS with multiple reaction monitoring. Percent enrichment of labeled CER 16:0 was calculated. Fractional synthetic rates (FSRs, pools/day) were determined by fitting single exponential curves to enrichment data. Absolute synthetic rates (ASRs, pmol/mg tissue/day) were calculated as FSR × pool size. Protein expression of CER synthetic enzymes and mitochondrial markers were measured by Western blot and enzymatic assays.
**Key Results:** After 2 weeks, HFD-fed animals had significantly greater body weight (27.1±4.7 vs 23.4±3.4 g, p<0.001), body fat (23±4% vs 13±4%, p<0.001), liver triglyceride content (20.9±5.5 vs 17.7±5.7 mg/g, p<0.001), serum FFA (0.31±0.05 vs 0.26±0.04 mmol/l, p=0.002), and serum glucose (13.7±2.4 vs 11.7±3.0 mmol/l, p=0.007) compared to CD. Total liver CER concentrations did not differ between diets, but saturated species 16:0, 18:0, and 20:0 were significantly higher in HFD (30%, 100%, and 115% respectively). Total mitochondrial CER concentrations were significantly greater with HFD, with increases in 16:0 (46%), 18:0 (128%), 20:0 (255%), 22:0 (68%), and 24:0 (116%). A positive correlation between total liver and mitochondrial CER was found only in HFD animals (r=0.360, p=0.012). HFD animals had a greater proportion of total liver CER in the mitochondrial pool (19±5% vs 12±4%, p<0.0001). Fractional synthesis of liver CER 16:0 was similar between diets (CD: ~0.5 pools/day, HFD: ~0.4 pools/day), but mitochondrial fractional synthesis was significantly greater in HFD (p<0.05). In CD, mitochondrial FSR was 31% lower than liver FSR; in HFD, mitochondrial FSR was 34% higher. ASR for liver 16:0 was similar between diets (15% difference), while mitochondrial ASR was 59% greater in HFD (p<0.05). Half-life of mitochondrial 16:0 CER was significantly longer with CD. Protein expression of SPT3 was higher in HFD, while CERS2 was lower (−22%) and DEGS1 was lower (−20%). Mitochondrial citrate synthase activity and electron transport chain complexes I–III and V were lower in HFD.
**Clinical Implications:** This study provides a novel, non-invasive method to measure in vivo CER synthesis in liver and mitochondria using oral serine isotope. The finding that short-term HFD increases mitochondrial CER content and turnover without altering total liver CER suggests that mitochondrial CER accumulation may be an early event in diet-induced metabolic dysfunction. This method can be used to investigate therapies targeting CER synthesis or degradation to reduce lipotoxicity in metabolic diseases such as type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease.